KYONGBO PHARMACEUTICAL CO., LTD. Logo

KYONGBO PHARMACEUTICAL CO., LTD.

A pharmaceutical company specializing in APIs, finished drugs, and CDMO services.

214390 | KO

Overview

Corporate Details

ISIN(s):
KR7214390007
LEI:
Country:
South Korea
Address:
충청남도 아산시 실옥로 174, 아산시

Description

Kyongbo Pharmaceutical Co., Ltd. is a pharmaceutical company specializing in the research, development, and manufacturing of Active Pharmaceutical Ingredients (APIs) and finished drug products. The company also operates as a Contract Development and Manufacturing Organization (CDMO), offering integrated services from early-stage development through to commercial cGMP production. Its core product portfolio includes a diverse range of APIs, such as sterile and non-sterile cephalosporins, carbapenem antibiotics, and high-potency cytotoxic anti-cancer agents. In addition to APIs, the company manufactures finished dosage forms, including solid oral medications and sterile injectables. Kyongbo Pharmaceutical utilizes dedicated and segregated manufacturing facilities to produce its specialized product lines, supported by a strong commitment to research and innovation in API synthesis.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-17 00:00
주식등의대량보유상황보고서(일반)
Korean 109.6 KB
2025-06-12 00:00
매매거래정지및정지해제(중요내용공시)
Korean 5.3 KB
2025-06-12 00:00
주요사항보고서(영업정지)
Korean 9.6 KB
2025-05-28 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.6 KB
2025-05-15 00:00
분기보고서 (2025.03)
Korean 973.7 KB
2025-05-07 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-04-25 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-04-25 00:00
영업(잠정)실적(공정공시)
Korean 13.3 KB
2025-04-15 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-04-15 00:00
최대주주등소유주식변동신고서
Korean 34.7 KB
2025-04-15 00:00
주식등의대량보유상황보고서(일반)
Korean 108.5 KB
2025-04-09 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-04-09 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.5 KB
2025-04-09 00:00
최대주주등소유주식변동신고서
Korean 41.4 KB
2025-04-09 00:00
주식등의대량보유상황보고서(일반)
Korean 111.6 KB

Automate Your Workflow. Get a real-time feed of all KYONGBO PHARMACEUTICAL CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for KYONGBO PHARMACEUTICAL CO., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for KYONGBO PHARMACEUTICAL CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Annexon, Inc. Logo
Clinical-stage biopharma developing complement medicines by inhibiting C1q.
United States of America
ANNX
ANTEROGEN CO., LTD. Logo
Develops and commercializes cell therapies and orphan drugs using adult stem cells.
South Korea
065660
Antibiotice S.A. Logo
Pharmaceutical firm manufacturing generic medicines, anti-infectives, and APIs.
Romania
ATB
Apellis Pharmaceuticals, Inc. Logo
Biopharmaceutical company developing therapies by targeting the complement cascade.
United States of America
APLS
Apimeds Pharmaceuticals US, Inc. Logo
Clinical-stage biopharma developing a bee venom drug and AI digital treasury solutions.
United States of America
APUS
Apogee Therapeutics, Inc. Logo
Clinical-stage biotech developing biologics for immunological and inflammatory diseases.
United States of America
APGE
Apollomics Inc. Logo
Clinical-stage biotech developing innovative oncology and combination therapies.
United States of America
APLM
Apontis Pharma AG Logo
Develops and markets fixed-dose combination drugs (Single Pills) for chronic diseases.
Germany
APPH
Applied Therapeutics, Inc. Logo
Clinical-stage biopharma developing novel drugs for rare metabolic and CNS diseases.
United States of America
APLT
Aprogen Biologics Inc. Logo
Develops and manufactures novel biologics and biosimilar antibody-based therapeutics.
South Korea
003060

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.